실시간
eLifeMaterial damage to multielectrode arrays after electrolytic lesioning is insignificantFierceBiotechHow data-driven diagnostic lab services drive precise clinical trial enrollmentFierceBiotechRedefining what success looks like in PSC: The evolution of clinical trial endpointsBioPharma DiveModerna flu vaccine wins unanimous support from FDA panelFierceBiotechModerna’s flu candidate sails through FDA advisory committee in unanimous votesEndpoints NewsFDA vaccine advisors unanimously support Moderna's flu shotScienceWolves are reconquering Europe. Can people learn to live with them?Clinical OMICsPakistan’s Massive Genetic Database Reveals Millions of Unique VariantsClinical OMICsFirst Novel Antifungal for Aspergillus in 20 Years Succeeds in Phase IIIBioWorldMoney raised by biopharmaBioWorldBiopharma money raised: Jan. 1-June 18, 2026Endpoints NewsTreasury weighs screening investments in China biotech
TSI Incorporated 2025년 5월 14일

Introducing TSI Tempo™ Hardware as a Service Program for Simplified, Hassle-Free Respiratory Fit Testing - GlobeNewswire

Introducing TSI Tempo™ Hardware as a Service Program for Simplified, Hassle-Free Respiratory Fit Testing - GlobeNewswire

본문을 이용할 수 없습니다. 원본 출처를 확인하세요.